Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Pharma
US details rules for pharmaceutical tariff exemptions
The 100% Section 232 tariffs on pharmaceutical imports kick in for all products today, except for certain specialty drugs.
Angus Liu
Sep 29, 2026 11:22am
Fierce Biotech
AstraZeneca scales Summit’s PD-1xVEGF combos with $2B investment
Sep 29, 2026 3:07am
Increased deaths shadow Enhertu’s first-line lung cancer data
Sep 13, 2026 7:00pm
Failed Trodelvy first-line NSCLC trial shows better China data
Sep 12, 2026 9:45pm
Daiichi promotes Ken Keller to lead new commercialization unit
Aug 24, 2026 4:32am
Biokin, BMS' bispecific ADC hits goal in China lung cancer trial
Aug 18, 2026 11:18am
